Welcome to our dedicated page for ZoomInfo Technologies news (Ticker: $ZI), a resource for investors and traders seeking the latest updates and insights on ZoomInfo Technologies stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ZoomInfo Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ZoomInfo Technologies's position in the market.
ZoomInfo (NASDAQ: ZI) has swept all six eligible categories in TrustRadius' Top Rated Awards for customer satisfaction, receiving more than 1,600 ratings reflecting best-in-class customer satisfaction. The company's solutions were recognized for sales intelligence, intent data, conversation intelligence, and more. ZoomInfo's commitment to delivering market-leading solutions powered by proprietary data has earned praise from verified users, highlighting the platform's effectiveness in helping sales teams sell smarter and win faster.
ZoomInfo announced its first quarter 2024 financial results, reporting a 3% year-over-year revenue growth, with GAAP revenue of $310.1 million and GAAP operating margin of 14%. The company also highlighted Adjusted Operating Income Margin of 39% and a GAAP Cash Flow from Operations of $115.9 million. ZoomInfo closed the quarter with 1,760 customers with $100,000 or greater in annual contract value and repurchased shares under an approved program. The business outlook includes guidance for the second quarter and full year 2024.